Literature DB >> 2009916

Mycobacterial proliferation in macrophages is prevented by incubation with lymphocytes activated in vitro with a mycobacterial antigen complex.

A Beschin1, L Brijs, P De Baetselier, C Cocito.   

Abstract

Antigen A60 from Mycobacterium bovis bacillus Calmette Guérin was shown to trigger both humoral and cellular immune reactions. We explored the ability of A60 to block intracellular proliferation of phagocytosed mycobacteria with a model system involving peritoneal murine macrophages infected with Mycobacterium avium. Mixed lymphocytes from lymph nodes of mice inoculated with A60 hindered intracellular proliferation of this mycobacterium, owing to A60-specific cells, proliferation of which was induced in vitro in an antigen concentration-dependent manner. The lymphokines released by A60-stimulated T lymphocytes in vitro were identified as interleukin 2 (IL2) and interferon-gamma (IFN-gamma): their production showed a clear A60 dose dependence. When supernatants of such induced lymphocyte cultures were incubated with anti-IFN-gamma antibodies, macrophage activation was prevented, whereas anti-IL 2 immunoglobulin had little effect. Treatment of infected macrophages with recombinant IFN-gamma reduced intracellular proliferation of mycobacteria, while exogenous IL 2 and tumor necrosis factor were ineffective. Therefore, A60 elicits in vitro proliferation of T lymphocytes responding specifically to this antigen with production of IFN-gamma, which in turn activates macrophages and prevents multiplication of phagocytosed mycobacteria.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2009916     DOI: 10.1002/eji.1830210336

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Immunization of mice with the antigen A60 of Mycobacterium bovis BCG.

Authors:  R D Hubbard; C M Flory; F M Collins; C Cocito
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

Review 2.  Paratuberculosis.

Authors:  C Cocito; P Gilot; M Coene; M de Kesel; P Poupart; P Vannuffel
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

3.  Lymphoproliferative responses to mitogens and prepared antigens of M. avium complex in patients with HIV infection.

Authors:  R M Novak; J Koirala; M L Sirdar; N D'Alfonso-Laghi; L Moreira; D L Pitrak; M Ghassemi
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

4.  Clinical usefulness of serological measurements obtained by antigen 60 in mycobacterial infections: development of a new concept.

Authors:  R Maes
Journal:  Klin Wochenschr       Date:  1991-10-02

5.  Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo.

Authors:  B Villarreal-Ramos; M McAulay; V Chance; M Martin; J Morgan; C J Howard
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

6.  Specificity of a protective memory immune response against Mycobacterium tuberculosis.

Authors:  P Andersen; I Heron
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

7.  Comparative cutaneous testing with purified protein derivative and the antigen complex A60 in vaccinated subjects and tuberculosis patients.

Authors:  Y L Zou; J D Zhang; M H Chen; G Q Shi; C Cocito
Journal:  Med Microbiol Immunol       Date:  1995-05       Impact factor: 3.402

8.  Comparison between bacillus Calmette-Guérin and the A60 mycobacterial antigen complex used as cancer-preventive immunotherapies.

Authors:  H Maes; H Taper; C Cocito
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

9.  Mycobacterial antigen complex A60-specific T-cell repertoire during the course of pulmonary tuberculosis.

Authors:  S Carlucci; A Beschin; L Tuosto; F Ameglio; G M Gandolfo; C Cocito; F Fiorucci; C Saltini; E Piccolella
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

10.  Evaluation of anti-A60 antigen IgG enzyme-linked immunosorbent assay for serodiagnosis of pulmonary tuberculosis.

Authors:  Zakeya Abdulbaqi Bukhary
Journal:  Ann Thorac Med       Date:  2007-04       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.